Does Dr. DAVID TRAN have financial conflicts of interest?

Dr. DAVID TRAN (MD PHD) has received a total of $114,623 in pharmaceutical and medical device industry funding between 2021 and 2025. This includes $114,623 in personal promotional payouts (consulting, meals, travel) and $0 in clinical research grants. Financial ties do not automatically imply conflict of interest, but are disclosed under the Sunshine Act.

Which pharmaceutical companies pay Dr. DAVID TRAN?

According to CMS Open Payments data, Dr. DAVID TRAN received funding from NOVOCURE ($110,377), MONTERIS MEDICAL CORPORATION ($4,055), and TELIX PHARMACEUTICALS ($133).

Does Dr. DAVID TRAN receive research grants or speaking fees?

Dr. DAVID TRAN has received $114,623 in general promotional payments (such as consulting honoraria, meals, and speaking fees) and $0 in clinical research grants.

DR. DAVID TRAN

MD PHDReal-Time Hydrated

Specialty: Internal Medicine, Medical Oncology

Practice Location: LOS ANGELES, CA 90033

NPI Number: 1184747024

LIFETIME INDUSTRY VALUE

$114,623

2021 – 2025 Cumulative

Conflict of Interest Analysis

Dr. TRAN is a verified Internal Medicine, Medical Oncology practitioner based in LOS ANGELES, CA.

Between 2021 and 2025, Dr. TRAN had an overall industry promotional and research financial footprint of $114,623 as recorded in the federal CMS Open Payments database.

$114,623 was received in general payments, which include consultation fees, travel expenses, honoraria, and sponsored meals.
$0 was allocated to sponsored clinical trials and medical research activities.

Dr. TRAN's primary funding source is NOVOCURE, which accounts for $110,377 (representing 96.3% of overall industry footprint).

Data coverage: 2021 – 2025 · Source: CMS Open Payments · CMS publishes each year's data around June 30 of the following year.

Payout Trend Over Time

General Payments

Research Funding

Top Funding Entities

Pharmaceutical & Device Manufacturers making direct payments

NOVOCURE

Rank 1

$110,377

96.3%

MONTERIS MEDICAL CORPORATION

Rank 2

$4,055

3.5%

TELIX PHARMACEUTICALS

Rank 3

$133

0.1%

Itemized Transaction Archives

Direct live query to Socrata CMS Open Payments API (Bypasses local DB)

Year:

2025

Filter < $250

Click "Load Live Logs" to query the federal Open Payments registry directly.

Frequently Asked Questions

Answers compiled using federal transparency disclosure records under the Sunshine Act.